A novel antagonist of the immune checkpoint protein adenosine A2a receptor restores tumor-infiltrating lymphocyte activity in the context of the tumor microenvironment - Mediavilla-Varela, M; Castro, J; Chiappori, A (Neoplasia, 2017)